In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were compared as maintenance immunosuppressive treatment of proliferative lupus nephritis (LN) after a short-course of intravenous cyclophosphamide. Here, we compare the pathological findings on repeat kidney biopsies between the two groups
Lupus nephritis (LN) increases the morbidity and mortality of patients with SLE. This review compare...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...
In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were compared as...
BACKGROUND: In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were...
Background: Long-term immunosuppressive treatment does not efficiently prevent relapses of lupus nep...
To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine (AZA) and myc...
Background Long-term immunosuppressive treatment does not effi ciently prevent relapses of lupus nep...
The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of debate. The pre...
OBJECTIVE: To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine (A...
BACKGROUND: Maintenance therapy, often with azathioprine or mycophenolate mofetil, is required to co...
Background: The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of deb...
Background: The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of deb...
Intravenous (IV) cyclophosphamide has been first-line treatment for inducing disease remission in lu...
Grootscholten et al. report a randomized controlled trial comparing azathioprine plus intravenous me...
Lupus nephritis (LN) increases the morbidity and mortality of patients with SLE. This review compare...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...
In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were compared as...
BACKGROUND: In the MAINTAIN Nephritis Trial, azathioprine (AZA) and mycophenolate mofetil (MMF) were...
Background: Long-term immunosuppressive treatment does not efficiently prevent relapses of lupus nep...
To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine (AZA) and myc...
Background Long-term immunosuppressive treatment does not effi ciently prevent relapses of lupus nep...
The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of debate. The pre...
OBJECTIVE: To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine (A...
BACKGROUND: Maintenance therapy, often with azathioprine or mycophenolate mofetil, is required to co...
Background: The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of deb...
Background: The ideal long-term maintenance therapy of Lupus Nephritis (LN) is still a matter of deb...
Intravenous (IV) cyclophosphamide has been first-line treatment for inducing disease remission in lu...
Grootscholten et al. report a randomized controlled trial comparing azathioprine plus intravenous me...
Lupus nephritis (LN) increases the morbidity and mortality of patients with SLE. This review compare...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...
There is not agreement about the best maintenance treatment for patients with diffuse lupus nephriti...